These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24048097)

  • 21. The μ-opioid receptor and treatment response to naltrexone.
    Thorsell A
    Alcohol Alcohol; 2013; 48(4):402-8. PubMed ID: 23543091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependence].
    Kato H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Oct; 43(5):697-704. PubMed ID: 19068776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Opioid antagonists and alcohol consumption].
    Barrios de Tomasi E; Juárez-González J
    Rev Neurol; 2007 Aug 1-15; 45(3):155-62. PubMed ID: 17661275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the Opioid Receptors: A Promising Therapeutic Avenue for Treatment in "Heavy Drinking Smokers".
    Domi A; Barbier E; Adermark L; Domi E
    Alcohol Alcohol; 2021 Feb; 56(2):127-138. PubMed ID: 33479741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The endogenous opioid system in human alcoholics: molecular adaptations in brain areas involved in cognitive control of addiction.
    Bazov I; Kononenko O; Watanabe H; Kuntić V; Sarkisyan D; Taqi MM; Hussain MZ; Nyberg F; Yakovleva T; Bakalkin G
    Addict Biol; 2013 Jan; 18(1):161-9. PubMed ID: 21955155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent developments in alcoholism:opioid peptides.
    Froehlich JC; Li TK
    Recent Dev Alcohol; 1993; 11():187-205. PubMed ID: 7901877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats.
    Gilpin NW; Richardson HN; Koob GF
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1535-42. PubMed ID: 18631323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the blockade of opioid receptors influence the development of ethanol dependence?
    Kotlińska J; Langwiński R
    Alcohol Alcohol; 1987; 22(2):117-9. PubMed ID: 2820433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.
    Soyka M; Rösner S
    Curr Drug Abuse Rev; 2008 Nov; 1(3):280-91. PubMed ID: 19630726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mu-, delta-, kappa-opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments.
    Fowler CJ; Fraser GL
    Neurochem Int; 1994 May; 24(5):401-26. PubMed ID: 7647696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetic treatments for drug addiction: alcohol and opiates.
    Haile CN; Kosten TA; Kosten TR
    Am J Drug Alcohol Abuse; 2008; 34(4):355-81. PubMed ID: 18584566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinically utilized kappa-opioid receptor agonist nalfurafine combined with low-dose naltrexone prevents alcohol relapse-like drinking in male and female mice.
    Zhou Y; Kreek MJ
    Brain Res; 2019 Dec; 1724():146410. PubMed ID: 31469985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of the cannabinoid CB1 receptor and alcohol dependence: preclinical evidence and preliminary clinical data.
    Maccioni P; Colombo G; Carai MA
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):55-9. PubMed ID: 20201816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Craving for alcohol: findings from the clinic and the laboratory.
    Sinha R; O'Malley SS
    Alcohol Alcohol; 1999; 34(2):223-30. PubMed ID: 10344782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.
    Weerts EM; Wand GS; Kuwabara H; Xu X; Frost JJ; Wong DF; McCaul ME
    Addict Biol; 2014 Jul; 19(4):733-42. PubMed ID: 23252742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal models of motivation for drinking in rodents with a focus on opioid receptor neuropharmacology.
    Koob GF; Roberts AJ; Kieffer BL; Heyser CJ; Katner SN; Ciccocioppo R; Weiss F
    Recent Dev Alcohol; 2003; 16():263-81. PubMed ID: 12638642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.
    Ray LA; Barr CS; Blendy JA; Oslin D; Goldman D; Anton RF
    Alcohol Clin Exp Res; 2012 Mar; 36(3):385-94. PubMed ID: 21895723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous opioids in the treatment of alcohol dependence. XIXth Collegium Internationale Neuro-Psycopharmacologium Congress. Washington, D.C., June 24, 1994.
    Alcohol; 1996; 13(1):1-106. PubMed ID: 8962671
    [No Abstract]   [Full Text] [Related]  

  • 40. GABA(A) and opioid receptors of the central nucleus of the amygdala selectively regulate ethanol-maintained behaviors.
    Foster KL; McKay PF; Seyoum R; Milbourne D; Yin W; Sarma PV; Cook JM; June HL
    Neuropsychopharmacology; 2004 Feb; 29(2):269-84. PubMed ID: 14666116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.